Showing results (1-10 of 505) with videos related to
Sort By:
Pageof 51
Current Opinion in Lipidology|January 19, 2016
Non-high-density lipoprotein cholesterol: current status as cardiovascular markerRutger Verbeek, G Kees Hovingh, S Matthijs BoekholdtAtherosclerosis|December 22, 2016
Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population studyNicolas Perrot, Rutger Verbeek, Manjinder Sandhu, et al.European Journal of Pharmacology|May 20, 2015
PCSK9 inhibitors: Novel therapeutic agents for the treatment of hypercholesterolemiaRutger Verbeek, Robert M Stoekenbroek, G Kees HovinghArteriosclerosis, Thrombosis, and Vascular Biology|November 19, 2016
Carriers of the PCSK9 R46L Variant Are Characterized by an Antiatherogenic Lipoprotein Profile Assessed by Nuclear Magnetic Resonance Spectroscopy-Brief ReportRutger Verbeek, Marjorie Boyer, S Matthijs Boekholdt, et al.Journal of Lipid Research|February 2, 2016
Population and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population StudyRutger Verbeek, S Matthijs Boekholdt, Robert M Stoekenbroek, et al.European Heart Journal|June 23, 2018
Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention settingRutger Verbeek, Renate M Hoogeveen, Anne Langsted, et al.Journal of Clinical Lipidology|September 26, 2018
Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population studyJulian C van Capelleveen, Sang-Rok Lee, Rutger Verbeek, et al.Current Opinion in Lipidology|July 10, 2004
CETP gene variation: relation to lipid parameters and cardiovascular riskS Matthijs Boekholdt, Jan-Albert Kuivenhoven, G Kees Hovingh, et al.Heart (British Cardiac Society)|January 18, 2015
High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial diseaseRobert M Stoekenbroek, S Matthijs Boekholdt, Rana Fayyad, et al.Current Opinion in Lipidology|March 16, 2005
Inherited disorders of HDL metabolism and atherosclerosisG Kees Hovingh, Eric de Groot, Wim van der Steeg, et al.Pageof 51